Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Micromedic Technologies Ltd. logo — Micromedic Technologies specializes in the development and c...

Micromedic Technologies Ltd.

Micromedic Technologies specializes in the development and commercialization of innovative in vitro cancer diagnostics

Founded 1982 Israel Israel 1 employees Post Ipo Equity Total: $21.00M Health Care

General Information

Company Name Micromedic Technologies Ltd.
Founded Year 1982
Location Israel Israel +1
Founders / Decision Makers
Team member
Employees 1
Industries Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Micromedic Technologies Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Micromedic Technologies Ltd.

Micromedic Technologies is a pioneering company in the field of in vitro cancer diagnostics. Founded in 1982 and headquartered in Israel, the company focuses on developing and commercializing cutting-edge diagnostic products and solutions for early cancer detection and personalized medicine. Their flagship product, CellDetect®, is a groundbreaking diagnostic platform with applications across multiple cancer types. It leverages a unique histochemical stain that allows color discrimination alongside morphological examination, enabling differentiation between normal and cancer cells in various sample types including biopsy, urine, smear, and blood. Micromedic's CellDetect® Bladder cancer test is a game-changer in the industry, offering high performance, cost-effectiveness, and a familiar workflow, unavailable in other bladder cancer tests. Clinical studies have demonstrated its high sensitivity for early-stage tumors, enhancing the prospect of early detection and prognosis improvement. The company received a ILS3.40M post-IPO equity investment on 01 January 2019 from Cybele Holdings. Micromedic's innovative technologies have the potential to revolutionize cancer diagnostics, facilitating pathologists' examination, reducing the need for expert analysis, and cutting lab costs. Their emphasis on early cancer detection and personalized medicine aligns with the increasing demand for advanced diagnostic solutions in the Health Care industry. With strong financial backing and a game-changing product portfolio, Micromedic is poised to make significant contributions to the future of cancer diagnostics and treatment.

Taxonomy: Cancer diagnostics, In vitro diagnostics, CellDetect technology, Bladder cancer test, Personalized medicine, Early cancer detection, Pathology, Clinical studies, Digital pathology, Tumor detection, Biopsy, Liquid-based cytology, Morphological examination, Color discrimination, Innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 1 •••• •••• 01 Jan 2019
Post-IPO Equity •••••• 1 •••• •••• 01 Jun 2018
Post-IPO Equity •••••• 1 •••• •••• 01 Dec 2017
Post-IPO Equity •••••• - 01 Sep 2017
Post-IPO Equity •••••• - 01 Jul 2016

View All 6 Funding Rounds

Micromedic Technologies Ltd. Alternatives & Competitors

Micromedic Technologies Ltd. vs
Nucleix Ltd.
Nucleix Ltd. Israel

Developing cancer diagnostic panels based on epigenetic bio markers

Unknown
72 employees
Biotechnology, Health Care
Compare Micromedic Technologies Ltd. vs Nucleix Ltd.
Micromedic Technologies Ltd. vs
BIDEA LLC
BIDEA LLC Puerto Rico

BIDEA LLC is a start-up company founded in 2016 for the R&D of point-of-care technologies for cancer...

Grant
2 employees
Health Care
Micromedic Technologies Ltd. vs
Mirxes
Mirxes Singapore

To Know. To Act: Our mission is to save and improve lives through early, actionable, and personalize...

154 employees

FAQ About Micromedic Technologies Ltd.

Micromedic Technologies specializes in the development and commercialization of innovative in vitro cancer diagnostics
Micromedic Technologies Ltd. was founded in 1982.
Micromedic Technologies Ltd. is headquartered in Israel.
Micromedic Technologies Ltd. operates in the following industries: Health Care.
Micromedic Technologies Ltd. has approximately 1 employees.
Micromedic Technologies Ltd. has completed 6 funding rounds, raising a total of $21.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Micromedic Technologies Ltd. include Nucleix Ltd., BIDEA LLC, Mirxes, LungLife AI, bioAffinity Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Micromedic Technologies Ltd. and Nucleix Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Micromedic Technologies Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes